PharmaTimes May 22, 2024
The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines
A new technology developed by researchers from King’s College London (KCL) could provide a new way of delivering drugs to advance next-generation treatments to prevent and treat a variety of diseases.
Published in the nanotechnology journal Small, the ‘plug and play’ technology could also lead to new therapeutics that act as both a vaccine and a drug, preventing disease and symptoms.
For over two decades, a common protein called ferritin, which manages iron in all organisms, has been used to create vaccines and deliver anticancer drugs, as well as other medicines, to the body.
Until now, scientists have been unable to develop a universal approach...
Today's Sponsors
Today's Sponsor